USA Metabotropic Glutamate Receptor 5 Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Metabotropic Glutamate Receptor 5 market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Metabotropic Glutamate Receptor 5 market. Detailed analysis of key players, along with key growth strategies adopted by Metabotropic Glutamate Receptor 5 industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Sumitomo Dainippon Pharma Co Ltd

    • Aevi Genomic Medicine Inc

    • Merz Pharma GmbH & Co KgaA

    • Heptares Therapeutics Ltd

    • Johnson & Johnson

    • Eisai Co Ltd

    • Richter Gedeon Nyrt

    • Eli Lilly and Company

    • Addex Therapeutics Ltd

    • Novartis AG

    • Toray Industries Inc

    • Bristol-Myers Squibb Company

    By Type:

    • Alloswitch-1

    • BMS-952048

    • BMS-955829

    • Dipraglurant ER

    • Others

    By End-User:

    • Major Depressive Disorder

    • Alcohol Addiction

    • Alzheimer's Disease

    • Others

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Metabotropic Glutamate Receptor 5 Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alloswitch-1 from 2016 to 2027

      • 1.3.2 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-952048 from 2016 to 2027

      • 1.3.3 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-955829 from 2016 to 2027

      • 1.3.4 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Dipraglurant ER from 2016 to 2027

      • 1.3.5 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Major Depressive Disorder from 2016 to 2027

      • 1.4.2 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alcohol Addiction from 2016 to 2027

      • 1.4.3 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alzheimer's Disease from 2016 to 2027

      • 1.4.4 USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Metabotropic Glutamate Receptor 5 Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Metabotropic Glutamate Receptor 5 by Major Types

      • 3.4.1 Market Size and Growth Rate of Alloswitch-1

      • 3.4.2 Market Size and Growth Rate of BMS-952048

      • 3.4.3 Market Size and Growth Rate of BMS-955829

      • 3.4.4 Market Size and Growth Rate of Dipraglurant ER

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Metabotropic Glutamate Receptor 5 Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Metabotropic Glutamate Receptor 5 by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Major Depressive Disorder

      • 4.4.2 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Alcohol Addiction

      • 4.4.3 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Alzheimer's Disease

      • 4.4.4 Market Size and Growth Rate of Metabotropic Glutamate Receptor 5 in Others

    5 Market Analysis by Regions

    • 5.1 USA Metabotropic Glutamate Receptor 5 Production Analysis by Regions

    • 5.2 USA Metabotropic Glutamate Receptor 5 Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 6.1 West USA Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 6.2 West USA Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    7 South USA Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 7.1 South USA Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 7.2 South USA Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    8 Middle West USA Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 8.1 Middle West USA Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 8.2 Middle West USA Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    9 Northeast USA Metabotropic Glutamate Receptor 5 Landscape Analysis

    • 9.1 Northeast USA Metabotropic Glutamate Receptor 5 Landscape Analysis by Major Types

    • 9.2 Northeast USA Metabotropic Glutamate Receptor 5 Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 Sumitomo Dainippon Pharma Co Ltd

        • 10.1.1 Sumitomo Dainippon Pharma Co Ltd Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Aevi Genomic Medicine Inc

        • 10.2.1 Aevi Genomic Medicine Inc Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Merz Pharma GmbH & Co KgaA

        • 10.3.1 Merz Pharma GmbH & Co KgaA Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Heptares Therapeutics Ltd

        • 10.4.1 Heptares Therapeutics Ltd Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Johnson & Johnson

        • 10.5.1 Johnson & Johnson Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Eisai Co Ltd

        • 10.6.1 Eisai Co Ltd Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Richter Gedeon Nyrt

        • 10.7.1 Richter Gedeon Nyrt Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Eli Lilly and Company

        • 10.8.1 Eli Lilly and Company Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Addex Therapeutics Ltd

        • 10.9.1 Addex Therapeutics Ltd Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Novartis AG

        • 10.10.1 Novartis AG Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Toray Industries Inc

        • 10.11.1 Toray Industries Inc Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Bristol-Myers Squibb Company

        • 10.12.1 Bristol-Myers Squibb Company Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alloswitch-1 from 2016 to 2027

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-952048 from 2016 to 2027

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of BMS-955829 from 2016 to 2027

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Dipraglurant ER from 2016 to 2027

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Major Depressive Disorder from 2016 to 2027

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alcohol Addiction from 2016 to 2027

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Alzheimer's Disease from 2016 to 2027

    • Figure USA Metabotropic Glutamate Receptor 5 Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Metabotropic Glutamate Receptor 5 Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Metabotropic Glutamate Receptor 5 Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Metabotropic Glutamate Receptor 5

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Metabotropic Glutamate Receptor 5 by Different Types from 2016 to 2027

    • Table Consumption Share of Metabotropic Glutamate Receptor 5 by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Alloswitch-1

    • Figure Market Size and Growth Rate of BMS-952048

    • Figure Market Size and Growth Rate of BMS-955829

    • Figure Market Size and Growth Rate of Dipraglurant ER

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Metabotropic Glutamate Receptor 5 by Different End-Users from 2016 to 2027

    • Table Consumption Share of Metabotropic Glutamate Receptor 5 by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Major Depressive Disorder

    • Figure Market Size and Growth Rate of Alcohol Addiction

    • Figure Market Size and Growth Rate of Alzheimer's Disease

    • Figure Market Size and Growth Rate of Others

    • Table USA Metabotropic Glutamate Receptor 5 Production by Regions

    • Table USA Metabotropic Glutamate Receptor 5 Production Share by Regions

    • Figure USA Metabotropic Glutamate Receptor 5 Production Share by Regions in 2016

    • Figure USA Metabotropic Glutamate Receptor 5 Production Share by Regions in 2021

    • Figure USA Metabotropic Glutamate Receptor 5 Production Share by Regions in 2027

    • Table USA Metabotropic Glutamate Receptor 5 Consumption by Regions

    • Table USA Metabotropic Glutamate Receptor 5 Consumption Share by Regions

    • Figure USA Metabotropic Glutamate Receptor 5 Consumption Share by Regions in 2016

    • Figure USA Metabotropic Glutamate Receptor 5 Consumption Share by Regions in 2021

    • Figure USA Metabotropic Glutamate Receptor 5 Consumption Share by Regions in 2027

    • Table West USA Metabotropic Glutamate Receptor 5 Consumption by Types from 2016 to 2027

    • Table West USA Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2016 to 2027

    • Figure West USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2016

    • Figure West USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2021

    • Figure West USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2027

    • Table West USA Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2016 to 2027

    • Table West USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2016

    • Figure West USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2021

    • Figure West USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2027

    • Table South USA Metabotropic Glutamate Receptor 5 Consumption by Types from 2016 to 2027

    • Table South USA Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2016 to 2027

    • Figure South USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2016

    • Figure South USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2021

    • Figure South USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2027

    • Table South USA Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2016 to 2027

    • Table South USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2016

    • Figure South USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2021

    • Figure South USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2027

    • Table Middle West USA Metabotropic Glutamate Receptor 5 Consumption by Types from 2016 to 2027

    • Table Middle West USA Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2016

    • Figure Middle West USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2021

    • Figure Middle West USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2027

    • Table Middle West USA Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2016

    • Figure Middle West USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2021

    • Figure Middle West USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2027

    • Table Northeast USA Metabotropic Glutamate Receptor 5 Consumption by Types from 2016 to 2027

    • Table Northeast USA Metabotropic Glutamate Receptor 5 Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2016

    • Figure Northeast USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2021

    • Figure Northeast USA Metabotropic Glutamate Receptor 5 Consumption Share by Types in 2027

    • Table Northeast USA Metabotropic Glutamate Receptor 5 Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2016

    • Figure Northeast USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2021

    • Figure Northeast USA Metabotropic Glutamate Receptor 5 Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Sumitomo Dainippon Pharma Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Dainippon Pharma Co Ltd

    • Figure Sales and Growth Rate Analysis of Sumitomo Dainippon Pharma Co Ltd

    • Figure Revenue and Market Share Analysis of Sumitomo Dainippon Pharma Co Ltd

    • Table Product and Service Introduction of Sumitomo Dainippon Pharma Co Ltd

    • Table Company Profile and Development Status of Aevi Genomic Medicine Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aevi Genomic Medicine Inc

    • Figure Sales and Growth Rate Analysis of Aevi Genomic Medicine Inc

    • Figure Revenue and Market Share Analysis of Aevi Genomic Medicine Inc

    • Table Product and Service Introduction of Aevi Genomic Medicine Inc

    • Table Company Profile and Development Status of Merz Pharma GmbH & Co KgaA

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merz Pharma GmbH & Co KgaA

    • Figure Sales and Growth Rate Analysis of Merz Pharma GmbH & Co KgaA

    • Figure Revenue and Market Share Analysis of Merz Pharma GmbH & Co KgaA

    • Table Product and Service Introduction of Merz Pharma GmbH & Co KgaA

    • Table Company Profile and Development Status of Heptares Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heptares Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Heptares Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Heptares Therapeutics Ltd

    • Table Product and Service Introduction of Heptares Therapeutics Ltd

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Eisai Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai Co Ltd

    • Figure Sales and Growth Rate Analysis of Eisai Co Ltd

    • Figure Revenue and Market Share Analysis of Eisai Co Ltd

    • Table Product and Service Introduction of Eisai Co Ltd

    • Table Company Profile and Development Status of Richter Gedeon Nyrt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Richter Gedeon Nyrt

    • Figure Sales and Growth Rate Analysis of Richter Gedeon Nyrt

    • Figure Revenue and Market Share Analysis of Richter Gedeon Nyrt

    • Table Product and Service Introduction of Richter Gedeon Nyrt

    • Table Company Profile and Development Status of Eli Lilly and Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company

    • Figure Sales and Growth Rate Analysis of Eli Lilly and Company

    • Figure Revenue and Market Share Analysis of Eli Lilly and Company

    • Table Product and Service Introduction of Eli Lilly and Company

    • Table Company Profile and Development Status of Addex Therapeutics Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addex Therapeutics Ltd

    • Figure Sales and Growth Rate Analysis of Addex Therapeutics Ltd

    • Figure Revenue and Market Share Analysis of Addex Therapeutics Ltd

    • Table Product and Service Introduction of Addex Therapeutics Ltd

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Toray Industries Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Toray Industries Inc

    • Figure Sales and Growth Rate Analysis of Toray Industries Inc

    • Figure Revenue and Market Share Analysis of Toray Industries Inc

    • Table Product and Service Introduction of Toray Industries Inc

    • Table Company Profile and Development Status of Bristol-Myers Squibb Company

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Company

    • Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Company

    • Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Company

    • Table Product and Service Introduction of Bristol-Myers Squibb Company


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.